PARTNER NEWS:Tue, Mar 5, 5:45 PM, Zacks
Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates Gritstone bio Inc. (GRTS) delivered earnings and revenue surprises of 27.78% and 116.31%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Mon, Feb 19, 4:49 AM, Zacks
TScan Therapeutics, Inc. (TCRX) Stock Jumps 18.1%: Will It Continue to Soar? TScan Therapeutics, Inc. (TCRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Featured MNV Articles: ZYME Crosses Below Key Moving Average Level
Wednesday, April 17, 4:49 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Zymeworks Inc (ZYME) crossed below their 200 day moving ...
WVE Crosses Below Key Moving Average Level
Wednesday, April 17, 4:49 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Wave Life Sciences Ltd (WVE) crossed below their 200 ...
Notable Two Hundred Day Moving Average Cross - SUPN
Wednesday, April 17, 4:45 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Supernus Pharmaceuticals Inc (SUPN) crossed below their 200 day ...
Paychex Breaks Below 200-Day Moving Average - Notable for PAYX
Wednesday, April 17, 4:43 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Paychex Inc (PAYX) crossed below their 200 day moving ...
Relative Strength Alert For Apellis Pharmaceuticals
Wednesday, April 17, 4:42 PM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|